IN BRIEF: Genedrive wins distribution agreements for Covid-19 test

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Genedrive PLC - Manchester-based molecular diagnostics company - Enters into distribution agreements covering Spain, Portugal, Oman and the United Arab Emirates for its Covid-19 test kit. The company says these initial distributor arrangements are designed to access and assess the longer-term market potential in each country. Genedrive says end-user product evaluation in the UK is currently ongoing and Covid-19 test device approval is pending.

Current stock price: 17.79 pence, up 23% on Wednesday
12-month change: down 84%

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.